Exactech, Inc.

Exactech, Inc. is a medical device company specializing in advanced orthopaedic implants and smart technologies that enhance joint replacement procedures and improve patient outcomes. Founded in 1985 in Gainesville, US, Exactech, Inc. develops innovative orthopaedic solutions.

The company was acquired by TPG in a Public to Private deal for USD 737 mn in 2017, transitioning its operations from public to private management. The leadership team includes Fabrizio Sardanelli, Gary Miller, and Robert Santrock, with Darin Johnson serving as CEO. Exactech specializes in innovative orthopaedic implants including knee, shoulder, hip, and foot and ankle systems. Their offerings are complemented by technologies such as ExactechGPS and Active Intelligence, aimed at improving surgical planning and postoperative recovery.

The company serves various clinical settings globally, including the US, Australia, Japan, Germany, France, and the UK, catering to hospitals and orthopaedic surgeons. In 2016, Exactech reported a revenue of USD 257. 57 mn, with an EBITDA of USD 26. 84 mn.

The revenue is generated through direct sales of orthopaedic implants and services to healthcare facilities, primarily through agreements with hospitals and surgical centers, focusing on institutional clients rather than direct-to-consumer sales. Flagship products such as the Newton Knee and Equinoxe Shoulder systems are central to their revenue generation. Exactech plans to leverage its recent acquisition to enhance growth and strengthen its market position. The funding from the acquisition will support the development of new products and a potential expansion into new markets.

The company will focus on launching upcoming innovations in joint replacement technology to enhance patient care while exploring opportunities in emerging markets outside the US by the end of 2018.